Siddhartha Mukherjee and Ken Burns hope The Gene will spark a national conversation. Photo: Stephanie Berger/Columbia University
NEW YORK Surging hope and semblance of solace in the age of the coronavirus comes in what may seem as strange indicators for laymen: New York state registered the largest number of deaths in a single day, on Tuesday, April 7, 2020, from the coronavirus since the crisis began. A staggering number of 731 people died in a day. Yet, there was cautious optimism as the rate of hospitalizations has fallen for several days, and the infections seem to be plateauing.
Gov. Andrew M. Cuomo, while revealing that 5,489 people had died in the state, said he was encouraged by the data on hospitalizations. He, however, cautioned against growing complacent or easing up on social distancing measures that seem to be working, reported The New York Times.
Cuomo said that increases in hospital beds and the number of health care providers who were working had helped New York to balance its patient load and help ensure that no one facility was overburdened.
The governor also said that planning was underway to restart the regional economy and that he had spoken to the governors of New Jersey and Connecticut about coordinating those efforts.
While the news on the lower number of hospitalizations may be encouraging for many, for families who are either victims or afflicted with the coronavirus, there was only misery, despair and dread to deal with.
A veteran Indian American journalist, Brahm Kanchibotla, from Hicksville, NY, was amongst the thousands who have died from the coronavirus, in New York. He breathed his last on April 6, after a cardiac arrest in a hospital in New York, after being admitted following symptoms of coronavirus. He is survived by his wife Anjana, and two children, son Sudama, and daughter Siujana.
Kanchibotla, who had worked for The Indian Express newspaper in Hyderabad, prior to emigrating to the US, worked also for the United News of India, from New York, and had worked as Content Editor for Merger Markets. He was 66 years old, according to Rajender Dichpally, a community activist.
Dichpally expressed his shock at the passing away of Kanchibotla, who he said was put on a ventilator at the hospital in New York, but didnt pull through.
He took his profession very seriously, said Dichpally. I remember when the late YSR Reddy had come to New York, in 2002. Kanchibotla wanted to interview him, and I managed to seat him next to YSR as he was having dinner, and Kanchibotla managed to get the interview.
Dichpally, who is from the Telugu diaspora, said that Kanchibotla also covered several Telugu association meets in the US, annually.
Mohammed Jaffer, the Editor of SnapsIndia, an international news photo service, based also in New Jersey, said that he knew Kanchibotla for the last 30 years, and they both were from the same hometown, Hyderabad.
I knew him for 30 years. He used to work for Indian Express Hyderabad, and he also used to work with my father there. He was a very humble and down to earth man, said Jaffer.
SIDDHARTHA MUKHERJEES NEW VENTURE
Indian American oncologist and writer Siddhartha Mukherjee and Ken Burns will present the PBS Premiere of The Gene: An Intimate History.
The ability to modify genes and prevent disease has exploded in the last decade. It is now possible to use gene therapy to cure inherited disorders, to correct genetic defects and to limit the severity of a disease. But this new era in genomic medicine offers both promise and peril, according to a report by Columbia University, where Mukherjee is on the faculty.
These revolutionary discoveries highlight the awesome responsibility that we have to make wise decisions, not just for the people alive today, but for generations to come, said Mukherjee, an assistant professor of medicine at Columbia University Irving Medical Center, staff cancer physician and author of The Gene: An Intimate History.
The Gene: An Intimate History, a four-hour, two-part documentary, will air April 7 and 14 on PBS stations nationwide. The series, like the book, weaves together science, history and stories of individuals and families, including Mukherjees account of his own family and its recurring pattern of mental illness.
The Gene airs at a critical moment for the science community, as geneticists around the world grapple with the ethical questions these technologies raise. In Nov. 2018, a Chinese researcher stunned and horrified the scientific community with the announcement that he had created the first genetically edited babies, twin girls born in China.
The documentary had been cut and finished just before the first cases of coronavirus were reported in China, so it was too late to include what would soon become the COVID-19 pandemic, a global crisis inextricably tied to our genes, Mukherjee said, reported Columbia University.
A piece of genetic material29,000-odd nucleotides of RNAcoated with protein has upended the world, Mukherjee said. Virtually every technology were using to track and treat COVID-19, even an oral or nasal swab to detect whether you are infected, relies on genetic techniques.
In an interview to Columbia News, Mukherjee sad that perhaps the most grotesque example of the misuse of the language of genetics is the Nazi eugenics program in the 1930s. The Nazis distorted the language of genes to imagine creating a genetically superior nationand then this was used to justify imprisonment and mass extermination.
Mukherjee was asked that if the concept of being able to order for $200 a profile of his or her genome that provides ancestral information, as well as genetic health risks, was positive or not.
He responded: The question you have to ask is do we want to live in a world where you can send a sample of saliva and find out that you have a 10 percent or 20 percent risk of developing breast cancer in the next 30 years. This information can be useful, motivating you to adopt more positive health behaviors. But it also marks you, changes you. It can change your relationship with yourself, your body. When you decide to test for future risk you are also, inevitably, asking yourself, what kind of future am I willing to risk?
Asked if genetics play a role in how vulnerable a person is to contracting COVID-19, and whether that person is more at risk of dying from the illness, he said this is one of the great mysteries of this infection. Young, healthy people are dying, even if most serious cases occur in the elderly and those with pre-existing conditions.
Mukherjee added: There are multiple studies trying to unravel why some people infected with SARS-Cov2, the virus that causes COVID-19, fall seriously ill, while others show only mild or nonexistent symptoms. We are finding a correlation between high viral loadthe amount of virus present in any sample taken from a patientand more severe illness.
Mukherjee had recently argued in The New Yorker that we have done a good job measuring the spread of the virus across populations, but it is now time we learn more about how SARS-Cov2 behaves in the body. This requires large-scale efforts to collect the DNA of people and the virus that they are infected with. One example of a study might be taking the DNA of those with serious underlying disease and comparing it to the DNA of those with mild or asymptomatic cases.
According to him, the medical fraternity need to determine whether genetic variations among humans affect how susceptible individuals are to COVID-19 infections as rapidly as possible.
(Sujeet Rajan is Executive Editor, Parikh Worldwide Media. Email him: sujeet@newsindiatimes.com Follow him on Twitter @SujeetRajan1)
Read more:
Death of a journalist, and Siddhartha Mukherjee on genes and COVID-19 - newsindiatimes.com
- Department of Genetic Medicine - January 6th, 2025
- Research Services | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Patient Care | Johns Hopkins Department of Genetic Medicine - January 6th, 2025
- Specialty Clinics | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Pediatric Genetic Medicine at Johns Hopkins Children's Center - January 6th, 2025
- Research Centers | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- About Us - Johns Hopkins Medicine - January 6th, 2025
- Graduate Programs & Training | Johns Hopkins Medicine - January 6th, 2025
- Request an Appointment | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021